Proprietary large-animal testing platform using genetically modified pigs to qualify cancer drugs, devices, diagnostics and therapies for pharmaceutical and biotech developers. Patent-pending methodology and novel clinical approaches reduce false positives, model multi-disease interactions, and accelerate progression to human trials.